ArticleACS central science2026

Correction to "Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression".

João Conde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.